Supply of Nonchemotherapy Compounded Monoclonal Antibodies
key details
| Value | £4,800,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | South East |
| Deadline | 5 Nov 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-04a5f9 |
Awards (4)
This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £4,800,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| BAXTER HEALTHCARE LIMITED shared | · | · | active |
| Qualasept Ltd t/a Bath ASU shared | · | · | active |
| Quantum Aseptic Services shared | · | · | active |
| Sciensus Pharma Services Limited shared | · | · | active |
description
Pharmacy Procurement Contract - Supply of Nonchemotherapy Compounded Monoclonal Antibodies. A Ranked Framework split into three LOTS<br/>LOT 1 - Infliximab Compounded Dose Banded Bags<br/>LOT 2 - Vedolizumab Compounded Bags<br/>LOT 3 - Natalizumab Compounded Bags<br/>The ranked framework will be open to participating Trusts of the South East Pharmacy Procurement Service.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 4 Oct 2024 | Contract notice (F02) | Earlier regulations | 031917-2024 |
| 1 Nov 2024 | Corrigendum (F14) | Earlier regulations | 035562-2024 |
| 6 Oct 2025 | Contract award notice (F03) | Earlier regulations | 062605-2025 |
more from Berkshire Healthcare NHS Foundation Trust
- UK-Bracknell-Out of area placements framework for inpatient rehabilitation (mental health) · £10,480,000 · 20 Jul 2026
- EBPOOH GP Cover Inpatient wards · 2 Jul 2026
- Mind in Berkshire Community Connector · 17 Jun 2026
- Burnham Physiotherapy MSK · 25 Feb 2026
- Empire Physiotherapy MSK · 25 Feb 2026
- Maidenhead Clinic Podiatry AQP COVID Recovery · 25 Feb 2026
- CIC High Intensity support Mental Health · 5 Jan 2026
- Broomwell ECG Interpretation · 5 Jan 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.